Lanean...
Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2
Introduction: Myotonic dystrophy type 2 (DM2) lacks disease-specific, validated, motor outcome measures (OMs), and patients' reported outcomes (PROs). This represents a limit for the monitoring of disease progression and treatment response. Our aim was to identify the most appropriate OMs to be...
Gorde:
| Argitaratua izan da: | Front Neurol |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7186332/ https://ncbi.nlm.nih.gov/pubmed/32373059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00306 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|